biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > have dots been connected yet, jd??

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Jan 03, 2025 8:18pm

121 Views

Post# 36387036

RE:RE:RE:RE:RE:RE:RE:RE:have dots been connected yet, jd??

The company failed. They are no longer operating. Several bigger pharma companies tested their technology and passed. No one had any interest in moving their technology forward. There is your evidence. I am not sure what other evidence you are looking for. I think it's been you who just doesn't get it.

<< Previous

Bullboard Posts

Next >>

How Canadian investors can benefit from flow-through shares